Prognostic relevance of anemia in myelodysplastic syndromes

被引：2

作者：

Cazzola, Mario

Malcovati, Luca

机构：

[1] Univ Pavia, Dept Hematol Oncol, I-27100 Pavia, Italy

[2] Fondaz IRCCS Policlin S Matteo, I-27100 Pavia, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2008年 / 83卷 / 10期

关键词：

D O I：

10.1002/ajh.21271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：761 / 762

页数：2

共 18 条

[1] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) :189-199

[2] Myelodysplastic syndromes - Coping with ineffective hematopoiesis [J].

Cazzola, M ;

Malcovati, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) :536-538

[3]

Deschler B, 2006, HAEMATOLOGICA, V91, P1513

[4]

Germing U, 2006, HAEMATOLOGICA, V91, P1596

[5] International scoring system for evaluating prognosis in myelodysplastic syndromes [J].

Greenberg, P ;

Cox, C ;

LeBeau, MM ;

Fenaux, P ;

Morel, P ;

Sanz, G ;

Sanz, M ;

Vallespi, T ;

Hamblin, T ;

Oscier, D ;

Ohyashiki, K ;

Toyama, K ;

Aul, C ;

Mufti, G ;

Bennett, J .

BLOOD, 1997, 89 (06) :2079-2088

[6] Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure [J].

Horwich, TB ;

Fonarow, GC ;

Hamilton, MA ;

MacLellan, WR ;

Borenstein, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1780-1786

[7] Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome [J].

Jadersten, Martin ;

Malcovati, Luca ;

Dybedal, Ingunn ;

Della Porta, Matteo Giovanni ;

Invernizzi, Rosangela ;

Montgomery, Scott M. ;

Pascutto, Cristiana ;

Porwit, Anna ;

Cazzola, Mario ;

Hellstrom-Lindberg, Eva .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3607-3613

[8] International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes [J].

Kao, Jelena M. ;

McMillan, Alex ;

Greenberg, Peter L. .

AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (10) :765-770

[9] Weighing the hazards of erythropoirsis stimulation in patients with cancer [J].

Khuri, Fadlo R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2445-2448

[10] Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making [J].

Malcovati, L ;

Della Porta, MG ;

Pascutto, C ;

Invernizzi, R ;

Boni, M ;

Travaglino, E ;

Passamonti, F ;

Arcaini, L ;

Maffioli, M ;

Bernasconi, P ;

Lazzarino, M ;

Cazzola, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7594-7603

← 1 2 →